Clinical Indication ID & Name
R183
Glucocorticoid-remediable aldosteronism (GRA)
Test Group
Endocrinology
Specialties
Test code
R183.1
Test name
N/A
Target genes
CYP11B1/CYP11B2 gene fusion
Test scope
n/a
Test method/ technology
Targeted mutation testing
Optimal Family Structure
n/a
Eligibility Criteria
Primary hyperaldosteronism with one of:
1. Presentation under the age of 30, OR
2. Family history of primary hyperaldosteronism or stroke below the age of 40
Commissioning group
Specialised
Overlapping idications
n/a
Address for samples/request forms
North Thames GLH, Rare & Inherited Disease Genomic Laboratory
Specimen Reception, Level 5 Barclay House, 37 Queen Square,
London WC1N 3BH
Contact with queries
Supporting documents
Rare Disese WGS Clinician pack
Education resources
n/a
Service updates
n/a
Request form download
Consent record
See consent guidance in test request form
Sample requirements
See sample guidance in test request form